Drug loading in cyclodextrin polymers: Dexamethasone model drug

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 69, Issue 3-4, 2011, Pages 377-382

  Moya Ortega, Maria D ^a   Messner, Martin ^a   Jansook, Phatsawee ^a   Nielsen, Thorbjørn Terndrup ^b   Wintgens, Veronique ^c   Larsen, Kim Lambertsen ^b   Amiel, Catherine ^c   Sigurdsson, Hákon H ^a   Loftsson, Thorsteinn ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b AALBORG UNIVERSITY   (Denmark)

^c CNRS   (France)

Author keywords

Cyclodextrin polymers; Dexamethasone; Drug loading; Solubility; Water soluble polymers

Indexed keywords

EID: 79955944720     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-010-9758-8     Document Type: Conference Paper

References (16)

1. Szejtli, J.: Cyclodextrin Technology. Kluwer, Dordrecht (1988)
2. Loftsson, T., Duchene, D.: Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 329, 1(2007)
3. Brewster, M. E., Loftsson, T.: Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59, 645(2007)
4. Loftsson, T., Frioriksdottir, H., Sigurdardottir, A. M., Ueda, H.: The effect of water-soluble polymers on drug-cyclodextrin complexation. Int. J. Pharm. 110, 169(1994)
5. Loftsson, T.: Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water-soluble polymers. Pharmazie 53, 733(1998)
6. Pose-Vilarnovo, B., Sanchez, C. R. T., Perez-Marcos, M. B., Torres-Labandeira, J. J.: Sulphamethizole-cyclodextrin-hydroxy propylmethyl cellulose multicomponent complexes. J. Therm. Anal. Calorim. 68, 657(2002)
7. Jansook, P., Loftsson, T.: γCD/HPγCD: synergistic solubilization. Int. J. Pharm. 363, 217(2008)
8. Jansook, P., Loftsson, T.: CDs as solubilizers: effects of excipients and competing drugs. Int. J. Pharm. 379, 32(2009)
9. Loftsson, T., Masson, M.: The effects of water-soluble polymers on cyclodextrins and, cyclodextrin solubilization of drugs. J. Drug Deliv. Sci. Tech. 14, 35(2004)
10. Hancock, B. C., Zografi, G.: Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86, 1(1997)
11. Mura, P., Faucci, M. T., Maestrelli, F., Furlanetto, S., Pinzauti, S.: Characterization of physicochemical properties of naproxen systems with amorphous β-cyclodextrin-epichlorohydrin polymers. J. Pharm. Biomed. Anal. 29, 1015(2002)
12. Nielsen, T. T., Wintgens, V., Larsen, K. L., Amiel, C.: Synthesis and characterization of poly (ethylene glycol) based β-cyclodextrin polymers. J. Incl. Phenom. Macrocycl. Chem. (2009). doi: 10.1007/s10847-009-9591-0
13. Renard, E., Deratani, A., Volet, G., Sebille, B.: Preparation and characterization of water soluble high molecular weight β-cyclodextrin- epichlorohydrin polymers. Eur. Polym. J. 33, 49(1997)
14. Wintgens, V., Amiel, C.: Water-soluble β-cyclodextrin polymers with high molecular weight and their complex forming properties. Polym. Int. (submitted)
15. Loftsson, T., Hreinsdóttir, D., Másson, M.: Evaluation of cyclodextrin solubilizations of drugs. Int. J. Pharm. 302, 18(2005)
16. Loftsson, T., Másson, M., Sigurdsson, H. H.: Cyclodextrins and drug permeability through semi-permeable cellophane membranes. Int. J. Pharm. 232, 35(2002)